CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 103 enrolled
Drug / intervention
MEDICother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00409240
NCT00409240Phase 3Completed
CompareCT.gov

Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

Providence VA Medical Center·interventional·Posted Dec 8, 2006·Updated Apr 11, 2014

In Brief

A Phase 3 clinical trial evaluating MEDIC for Diabetes and 2 related conditions. Completed, enrolled 103 participants across 1 site.

Detailed Summary

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Hypertension, Dyslipidemia
CountriesUnited States
CollaboratorsSandra A. Daugherty Foundation

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 8, 2006
Enrollment StartOct 1, 2006
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 19.6 years ago

Interventions

MEDICother

Multidisciplinary Education and Diabetes Intervention for Cardiac risk reduction (MEDIC; a pharmacist-led behavioral and pharmacologic intervention in groups.